Flow cytometric analysis of CRT on the cell surface 3.105 EL4 Thymoma cells, growing in suspension in RPMI 1640 (Gibco) supplemented medium were plated in 12-well plates and treated with mitomycin C (30mM, Sanofi Aventis)
Calreticulin (human) (rec.) (His)
AG-40A-0132
Overview
- SupplierAdipoGen Life Sciences
- Product NameCalreticulin (human) (rec.) (His)
- Delivery Days Customer10
- CertificationResearch Use Only
- Concentration0.2 mg/ml
- Estimated Purity>90%
- FormulationLiquid
- Protein IDP27797
- Protein NameCalreticulin
- Scientific DescriptionCalreticulin is involved in regulation of intracellular Ca2+ homoeostasis and ER Ca2+ capacity. It constitutes together with calnexin and ERp57 the calreticulin/calnexin cycle that is responsible for folding and quality control of newly synthesized glycoproteins. Calreticulin has been implicated to play a role in many biological systems, including functions inside and outside the ER, indicating that the protein is a multi-process molecule. Recently, Calreticulin was shown to enhance the merger of macrophages and tumor cells, increasing phagocytosis. - Protein. Human calreticulin (aa18-417) is fused at the C-terminus to a His-tag. Source: E. coli. Endotoxin content: <1EU/microg purified protein (LAL test; Lonza). Liquid. 0.2microm-filtered solution in 55mM TRIS-Cl, pH 8.2, containing 150mM NaCl. Purity: >90% (SDS-PAGE). Calreticulin is involved in regulation of intracellular Ca2+ homoeostasis and ER Ca2+ capacity. It constitutes together with calnexin and ERp57 the calreticulin/calnexin cycle that is responsible for folding and quality control of newly synthesized glycoproteins. Calreticulin has been implicated to play a role in many biological systems, including functions inside and outside the ER, indicating that the protein is a multi-process molecule. Recently, Calreticulin was shown to enhance the merger of macrophages and tumor cells, increasing phagocytosis.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352202